AI Company Signs Major Deal with Apple

On December 13, 2022, a Big Pharma giant quietly bought one AI-designed drug for $4 billion.   That makes it the biggest deal for an AI-designed drug in history.   But very few people even know about it...yet.   Even leading investors in the U.S. have no idea.   And they don't know that this tiny AI-biotech designed the drug.   But this won't stay quiet much longer.   On January 9, 2023, Bristol Myers Squibb signed a $2.7 billion deal to have their AI-platform develop six new drugs.   On October 6, 2022, Eli Lilly signed a $425 million deal to have their AI-platform develop a new drug.   These seven drugs alone could bring $28 billion to this little-known company.   That doesn't include deals they signed with Sanofi, Nimbus Therapeutics, Petra Pharma and others.   Wall Street doesn't yet grasp how this company is quietly revolutionizing the drug discovery business...   Which is why I believe this will be the biggest AI winner you never heard of.   Get the name of the stock here...while it's still a small-cap >>>   "The Buck Stops Here," 4477 Fulton Industrial Blvd SW, Ste A1, Atlanta, GA 30336, United States This editorial email containing advertisements was sent to diansastroxz.forex@blogger.com because you subscribed to this service. Disclaimer: Readers are advised that this publication is issued solely for informational purposes. This editorial should not be considered as investment advice, a broker-dealer, or financial adviser and does not provide any individualized investment advice to you. Readers are advised that this publication is issued solely for informational purposes. Trading involves risks. Unsubscribe Me | Report Spam